Breaking News

You are here » Indian-Commodity  :  Equity & Shares  :  Alembic Pharma rises on getting USFDA's nod for Alogliptin, Metformin Hydrochloride Tablets

14-Sep2018

Alembic Pharma rises on getting USFDA's nod for Alogliptin, Metformin Hydrochloride Tablets

Alembic Pharmaceuticals is currently trading at Rs. 647.10, up by 6.90 points or 1.08% from its previous closing of Rs. 640.20 on the BSE.

The scrip opened at Rs. 641.00 and has touched a high and low of Rs. 652.00 and Rs. 637.50 respectively. So far 7567 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 657.00 on 12-Sep-2018 and a 52 week low of Rs. 412.40 on 24-May-2018.

Last one week high and low of the scrip stood at Rs. 657.00 and Rs. 597.55 respectively. The current market cap of the company is Rs. 12144.20 crore.

The promoters holding in the company stood at 72.96%, while Institutions and Non-Institutions held 14.30% and 12.74% respectively.

Alembic Pharmaceuticals has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Alogliptin and Metformin Hydrochloride Tablets, 12.5 mg/500 mg and 12.5 mg/1000 mg. The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), KAZANO Tablets, 12.5 mg/500 mg and 12.5 mg/1000 mg of Takeda Pharma USA. Alogliptin and Metformin Hydrochloride Tablets, 12.5 mg/500 mg and 12.5 mg/1000 mg are indicated as an adjunct to diet and exercise to improve giycemic control in adults with type 2 diabetes mellitus when treatment with both alogliptin and metformin is appropriate.

Alogliptin and Metformin Hydrochloride Tablets, 12.5 mg/500 mg and 12.5 mg/1000 mg has an estimated market size of $22.5 million for twelve months ending December 2017 according to IQVIA. Alembic now has a total of 77 ANDA approvals (64 final approvals and 13 tentative approvals) from USFDA. 

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.


Related News

View all news

Sacheta Metals surges on bagging order worth Rs 360 million from Mozambique

Sacheta Metals is currently trading at Rs. 46.45, up by 1.50 points or 3.34 % from its previous closing of Rs. 44.95 on the BSE.The scrip opened at Rs. 45.00 and has touched a high and low of Rs. 48.50......

RPP Infra Projects surges on bagging orders worth Rs 62.90 crore from BHEL

RPP Infra Projects is currently trading at Rs. 131.00, up by 3.35 points or 2.62% from its previous closing of Rs. 127.65 on the BSE.The scrip opened at Rs. 128.00 and has touched a high and low of Rs.......

PVR gains on the bourses

PVR is currently trading at Rs. 1602.75, up by 4.05 points or 0.25% from its previous closing of Rs. 1598.70 on the BSE.The scrip opened at Rs. 1604.40 and has touched a high and low of Rs. 1607.35 and......

Top News

View all news

RPP Infra Projects bags orders worth Rs 62.90 crore from BHEL

RPP Infra Projects has bagged orders from Bharat Heavy Electricals (BHEL), Chennai for worth of Rs 62.90 crore. The first order is for providing civil works of Boiler, Mill and Bunker, ESP area of unit......

Glenmark gets tentative ANDA approval for Abiraterone Acetate Tablets

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted tentative approval by the United States Food & Drug Administration (USFDA) for Abiraterone Acetate Tablets USP, 250 mg, a generic......

HDFC Standard Life Insurance reports 18% rise in Q3 net profit

HDFC Standard Life Insurance has reported results for third quarter ended December 31, 2018. The company has reported a rise of 18.48% in its net profit at Rs 245.63 crore for the quarter under review......